Gauruv Bose
@gauruv
MS Neurologist @OttawaHospital | Assistant Professor @uOttawaMed | Associate Scientist OHRI | Fellowship @MassGenBrigham @HarvardMed
ID: 216853383
https://www.ohri.ca/profile/BoseLab 17-11-2010 22:13:09
113 Tweet
180 Followers
455 Following
Thank you President Donald J. Trump for highlighting the struggles many people living with MS face when it comes to accessing the medications they need to live their best lives. Learn more about access to MS medications at nationalmssociety.org/accessmeds #MSActivist
This is it- 10 million adults, 20y follow-up. 801 dx w/MS VS 1500+ controls: EBV seroconversion occurred in ALL who developed MS, except 1. We have the target—let’s fund the treatment! Science Magazine Harvard T.H. Chan School of Public Health National MS Society @MSSocietyCanada science.org/doi/10.1126/sc…
Well deserved appointment and great for Brigham and Women's Neurology! Dr. Chitnis is also the director of the #CLIMBStudy and PI for #Foralumab Phase-1b for #MultipleSclerosis, and #Protollin Phase-1 for #AlzheimersDisease — also a fantastic mentor & fellowship director, congratulations!
Today we said goodbye to Dr. Gauruv Bose Bose, our neuroimmunology clinical fellow in Mass General Brigham! He is not only a great neurologist, but also a wonderful human being! Diligent, committed and professional! Goodluck Gauruv Bose! You definitely deserve the bests!
Our latest paper from MGH Neurology is now online on MSJ! Thansk to my mentor Michael Levy, MD, PhD and my colleagues Gauruv Bose and@ItayLotan for their support and contribution. journals.sagepub.com/doi/10.1177/20… SAGE Publications MassGeneral News Mass General Brigham/HMS Neurology Residency Mass General Brigham MassGeneral Medicine
New scientist alert! Dr. Gauruv Bose Bose aims to use AI and #BigData to predict the course of #MultipleSclerosis. ohri.ca/newsroom/story…
What would make an #ideal #biomarker ? Combining biomarkers as an approach? Dr. Gauruv Bose of #Ottawa Gauruv Bose Ahmed Z Obeidat, MD, PhD #CMSC2023 #serumNfL #GFAP #MRI NeurologyLive®
Can we predict contrast+ lesions in #MultipleSclerosis using serum neurofilament #NfL? Best performance in <50 years, for NfL >23.0 pg/mL (sens 25%, spec 95%) or 30.8% increase (sens 52%, spec 81%). Study from Gauruv Bose Mass General Brigham Harvard Medical School ▶️ journals.sagepub.com/doi/full/10.11…
Check out our new paper on Progression Independent of Relapse Activity (PIRA) in NMOSD, MOGAD and MS! Special thanks to my incredible mentor, Dr. Michael Levy, MD, PhD , and to my colleagues for their valuable collaboration! Gauruv Bose MGH Neurology Brigham and Women's Neurology sciencedirect.com/science/articl…